Berlin, Germany

Claudia Aldenhoven


 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 43(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):

Title: Claudia Aldenhoven: Innovator in Inhaler Technology

Introduction

Claudia Aldenhoven is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of inhaler technology, particularly with her innovative designs that enhance the delivery of volatile substances. Her work is characterized by a commitment to improving health outcomes through advanced engineering solutions.

Latest Patents

Claudia holds a patent for an "Inhaler system for volatile substances." This invention relates to a depot for storing and dispensing a substance into a gas phase. It features a hybrid structure made of an open-pored macroporous support skeleton, allowing gas flow, and nanoporous particles immobilized on the support skeleton. These particles contain at least one active ingredient to be released, with the support skeleton consisting of particles or fibers that are permanently connected to each other. This innovative design aims to improve the efficiency and effectiveness of inhalation therapies.

Career Highlights

Claudia Aldenhoven is associated with Surflay Nanotec GmbH, where she applies her expertise in developing cutting-edge inhalation systems. Her work at the company has positioned her as a leader in the field, contributing to advancements that benefit patients and healthcare providers alike.

Collaborations

Claudia collaborates with talented professionals such as Lars Siegfried Dähne and Gabriella Egri. These partnerships enhance her research and development efforts, fostering an environment of innovation and creativity.

Conclusion

Claudia Aldenhoven's contributions to inhaler technology exemplify her dedication to improving health solutions through innovation. Her patent and work at Surflay Nanotec GmbH highlight her role as a key figure in the advancement of inhalation therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…